Cidara Therapeutics, Inc.
CDTX
Rang in aandelen
#3185
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Aandeelprijs
$221.38
Laatst gesynchroniseerd: 2026-01-08
Marktkapitalisatie
$5.61B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
120.15%
Land
US
Handel Cidara Therapeutics, Inc. (CDTX)
Categorie
Healthcare
Aandelsplitsingen voor Cidara Therapeutics, Inc. (CDTX)
Het aandeel Cidara Therapeutics, Inc. (symbool: CDTX) heeft in totaal 1 splitsingen ondergaan.
De meest recente splitsing vond plaats op Apr 24, 2024.
Eén aandeel CDTX dat vóór Apr 24, 2024 werd gekocht, staat nu gelijk aan 0.05 aandelen CDTX.
De meest recente splitsing vond plaats op Apr 24, 2024.
Eén aandeel CDTX dat vóór Apr 24, 2024 werd gekocht, staat nu gelijk aan 0.05 aandelen CDTX.
Lijst van aandelen splitsingen
| Jaar | Splitsing | Vermenigvuldiging | Cumulatieve vermenigvuldiging |
|---|---|---|---|
| 2024-04-24 | 1:20 | x0.05 | x0.05 |
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten
| Bedrijf | Aantal aandelen splitsingen | Cumulatieve vermenigvuldiging | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
